CDC/IDSA COVID-19 Clinician Call - Immunomodulatory Agents - Therapies Targeting Cytokine Storm in COVID-19

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Read responses to unanswered questions and register for next week here. 

Moderator:

• Dana S. Wollins, DrPH, MGC
  Vice President, Clinical Affairs & Practice Guidelines, IDSA

Presenters:

• Cassandra Calabrese, DO
  Cleveland Clinic Foundation
  Department of Rheumatologic and Immunologic Disease
  Department of Infectious Disease

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.